Substituted guanidines and the use thereof

Details Substituted guanidines and the use thereof Substituted guanidines and the use thereof

2005-04-05

2005-04-05

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252120, C514S634000, C544S358000, C544S401000, C544S403000

Reexamination Certificate

active

06875759

ABSTRACT:
A method for the treatment of cancer and pain in an animal subject is disclosed, comprising administering to said animal in need of such treatment an effective amount of a compound of formula I:wherein R1-R6are defined herein. Pharmaceutical compositions comprising one or more compounds of formula I and a pharmaceutically acceptable carrier are also disclosed.

REFERENCES:
patent: 3501557 (1970-03-01), Brois et al.
patent: 3961056 (1976-06-01), DuCharme
patent: 4281004 (1981-07-01), Ives
patent: 4686283 (1987-08-01), Nestor et al.
patent: 4709094 (1987-11-01), Weber et al.
patent: 4906779 (1990-03-01), Weber et al.
patent: 5093525 (1992-03-01), Weber et al.
patent: 5190976 (1993-03-01), Weber et al.
patent: 5262568 (1993-11-01), Weber et al.
patent: 5312840 (1994-05-01), Keana et al.
patent: 5385946 (1995-01-01), Keana et al.
patent: 5403861 (1995-04-01), Goldin et al.
patent: 5478863 (1995-12-01), Keana et al.
patent: 5502255 (1996-03-01), Keana et al.
patent: 5510380 (1996-04-01), Seoane et al.
patent: 5574070 (1996-11-01), Keana et al.
patent: 5604228 (1997-02-01), Keana et al.
patent: 5608106 (1997-03-01), Fried et al.
patent: 5614630 (1997-03-01), Goldin et al.
patent: 6057371 (2000-05-01), Glennon
patent: 6103719 (2000-08-01), Esser et al.
patent: GB0618147 (1906-08-01), None
patent: 355121 (1922-06-01), None
patent: 19824470 (1999-12-01), None
patent: 86300123.6 (1986-07-01), None
patent: 0 188 333 (1989-07-01), None
patent: 57-24366 (1982-02-01), None
patent: 55099171 (1982-02-01), None
patent: WO 9014067 (1990-11-01), None
patent: WO 9109594 (1991-07-01), None
patent: WO 9112797 (1991-09-01), None
patent: WO 9113056 (1991-09-01), None
patent: WO 9118868 (1991-12-01), None
patent: WO 9214697 (1992-09-01), None
patent: WO 9300313 (1993-01-01), None
patent: WO 8800583 (1998-01-01), None
patent: WO 9823267 (1998-06-01), None
patent: WO 9962893 (1999-12-01), None
patent: WO 0072800 (2000-12-01), None
patent: WO 0072840 (2000-12-01), None
Thomas et al, J. Medicinal Chem. 32/1,228-36(1989), also cited as Chemical Abstract DN:110:38957.*
Sartippour et al, PubMed Abstract 12680218, also cited as Anticancer Res. 23/1,231-4 (2003).*
Burd et al(PubMed Abstract 12600235, also cited as Radiat. Res. 159/3,328-35(2003).*
Uckun et al(Current Cancer Drug Targets, 1,59-71 (2001).*
Celi Textbook of Medicine, Edited by Bennett et al, W.B.Saunders Co.,1996, pp. 1004-1010.*
PubMed Abstract 12677247, also cited as Drug News Perspect 15/10,626-6322002).*
PubMed Abstract 12760986 also cited as Anesth. Analg. 96/6, 1631-5(2003).*
PubMed Abstracxt 10856067, also cited as BMJ 320/7250, 1642-6(2000).*
Thomas E.W. et al,“J. of Med. Chemistry”,Synthesis of acylguanidine analogs; 32/1, 228-36(1989).*
Adler, P., et al., “The effect of structurally different local anesthetics on the cholinesterase activity of human serum,” Zeitschrift fuer Vitamin, Hormon, und Fermentforschung (1950) 3, 236-43 Abstract (German).
Bender, “The formation of guianidine derivs . . . ” Ann. Univ. Sci. Budapest Rolando Eotvos Nominaiae Sect. Chim 1, 136-41 (1959) Abstract German.
Doughty, M.B., et al., “Non-peptide Mimics of Neuropeptide Y: Analysis of Benextramine Structure-Activity Relationships at Y1and Y2Receptors,” Peptides: Chemistry, Structure and Biology 1996.
Humphrey, S.J., et al., “Cardiovascular Effects of the K-ATP Channel Blocker U-37883A and Structurally Related Morpholinoguanidines,” Meth. Find. Exp. Clin Pharmacol. 1996 18(4): 247-260.
Kishore, Vimal et al., “Anti-Inflammatory and Antiproteolytic Properties of Substituted Guanidines,” Pharmacology 15: 97-103 (1977).
Knieps, S., et al., “ω-Phenyl-ω-(2-pyridyl)alkyl-substituted bisguanidines are moderate neuropeptide Y antagonists,” Pharm Pharmacol. Let 6 (1996) 1: 27-10.
LeBrocq, C.N., “Local Anesthetics Recommended as Substitutes for Cocaine,”: Pharmaceutical Journal (1909) 82, 673-674.
Siddiqui, N., et al., “Analgesic and hypnosis potentiation effect of some 1-(2-benzothiazolyl)1-aryl-3-phenyl-4-aryl guanidines,” Indian Journal of Experimental Biology, vol. 30, Sep. 1992, pp. 811-813.
Adock, B. and Lawson, A., “2-Amino-2-imidazolines and 2-Amino-2-oxazolines. Part II.,”Journal of The Chemical Society474-479, The Chemical Society, Burlington House (1965).
Dollinger, H. et al., “New guanidine and amidine derivatives useful in treatment of e.g. inflammatory and allergic conditions, central nervous system disorders, tumors, herpes zoster, etc.,” Dialog File 351, WPI Acc. No. 2000-063491/200006, Derwent WPI English language abstract of DE 19824470 (Document AM3).
Doughty, M.B. et al., “Non-peptide Mimics of Neuropeptide Y: Analysis of Benextramine Structure-Activity Relationships at Y1and Y2Receptors,” inPeptides: Chemistry, Structure and Biology,Kaumaya, P.T.P. and Hodges, R.S., eds., Mayflower Scientific Ltd., England, pp. 711-712 (1996).
Dyson, G.M. and Harrington, T., “The Action of Chlorine on Aryl Thiocarbimides and the Reactions of Aryl isoCyanodichlorides,”Journal of The Chemical Society191-194, The Chemical Society, Burlington House (1940).
Fridland, S.V. et al., “Reaction of N,N′-Diphenylguanidine with Esters of Methylphosphonic Acid,”Zhurnal Obshchei Khimii 66:791-793, Maik Nauka/Interperiodica Publishing (1996).
Fridland, S.V. et al., “Reaction of N,N′-Diphenylguanidine with Esters of Methylphosphonic Acid,”Russian Journal of General Chemistry 66:772-773, Maik Nauka/Interperiodica Publishing (1996).
Humphrey, S.J. et al., “Cardiovascular Effects of the K-ATP Channel Blocker U-37883A and Structurally Related Morpholinoguanidines,”Methods and Findings in Experimental and Clinical Pharmacology 18:247-260, Prous Science (1996).
Jefferson, R. et al., “Chloroboration and Allied Reactions of Unsaturated Compounds. Part IV. Boration of Di-p-Tolylcarbodi-imide,”Journal of The Chemical Society(A) 1584-1590, The Chemical Society, Burlington House (1966).
Kishore, V. et al., “Anti-Inflammatory and Antiproteolytic Properties of Substituted Guanidines,”Pharmacology 15:97-103, S. Karger (1977).
Knieps, S. et al., “ω-Phenyl-ω-(2-pyridyl)alkyl-substituted bisguanidines are moderate neuropeptide Y antagonists,”Pharmaeutical and Pharmacological Letters 6:27-30, medpharm Scientific Publishers (1996).
Ram, V.J. et al., “Synthesis of Some New Thioureas and Guanidines Derived from p-Amino n-Butyl and Iso-Butyl Benzoates,”The Indian Journal of Pharmacy 35:30-32, The Indian Pharmaceutical Association (1973).
Ramadas, K. et al., “A Short and Concise Synthesis of Guanidines,”Synlett 9:1053-1054, Thieme Stuttgart (1997).
Shionogi & Co Ltd., “Carcinostatic 2-(1-imidazolyl) amidine cpds.—preptd. from phenyl-thiourea deriv. and N,N′-thionyl-diimidazole,” Dialog File 351, WPI Acc No. 1982-21122E/198211, Derwent WPI English language abstract of JP 57-24366 (Document AL1).
Siddiqui, N. et al., “Synthesis of Benzothiazolyl Guanidine Derivatives as Potent Anticonvulsants,”Pharmakeftiki 5:121-125, Pharmaceutical Publications Ltd. (1992).
Siddiqui, N. and Pandeya, S.N., “Analgesic and hypnosis potentiation effect of some 1-(2-benzothiazolyl)-1-aryl-3-phenyl-4-aryl guanidines,”Indian J. of Exp. Biol. 30:811-813, Publications & Information Directorate (1992).
Singh, T. et al., “E.P. Activity Assessment of Certain Nitrogen and Sulphur Heterocyclic Compounds as Potential Additives in Four Ball Test©,”Lubrication Engineering 46:681-685, The Society of Tribologists and Lubrication Engineers (1990).
Szekerke, M. and Csazar, J., “Reaction readiness of carbodiimides with primary amines,”Chemical Abstracts 56:col. 4591, line 82, through col. 4592, line 13, The American Chemical Society (1962).
Thomas, E.W. et al., “Synthesis of Acylguanidine Analogues: Inhibitors of AD

Affiliated with

Also associated with

Rating

Substituted guanidines and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted guanidines and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted guanidines and the use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3399397